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Abstract Homeostatic regulation protects organisms against hazardous physiological changes.
However, such regulation is limited in certain organs and associated biological processes. For
example, the heart fails to self-restore its normal electrical activity once disturbed, as with
sustained arrhythmias. Here we present proof-of-concept of a biological self-restoring system that
allows automatic detection and correction of such abnormal excitation rhythms. For the heart, its
realization involves the integration of ion channels with newly designed gating properties into
cardiomyocytes. This allows cardiac tissue to i) discriminate between normal rhythm and arrhythmia
based on frequency-dependent gating and ii) generate an ionic current for termination of the
detected arrhythmia. We show in silico, that for both human atrial and ventricular arrhythmias,
activation of these channels leads to rapid and repeated restoration of normal excitation rhythm.
Experimental validation is provided by injecting the designed channel current for arrhythmia
termination in human atrial myocytes using dynamic clamp.
Introduction
Living organisms strive to maintain a stable internal environment through continuous regulation of
the body’s physiological processes. Such homeostatic regulation involves three principal mecha-
nisms: detection, processing and effectuation. The ‘detector’ senses a change in the environment,
communicates it to a ‘processor’, which processes the information and commands the ‘effector’ to
react appropriately (Horrobin, 1970). Given their highly conserved nature, these ‘detector-effector’
(DE) systems are considered to be effective means to respond to changes that, if sustained, may
cause harm to the organism. Light sensitivity coupled to movement is an example of a detector-
effector mechanism for the full scale of evolved organisms, as exemplified by phototaxis in unicellu-
lar organisms (Nagel et al., 2002) and pupil reflex in higher order vertebrates (Sherman and Stark,
1957). At the cellular level, many DE systems operate through ion channels, which may act as func-
tional detector-effector units. These channels can detect changes in, for example, voltage, hormones
or light to which they respond by activation to generate a flow of ions (i.e. an electrical current) or
by inactivation to stop a flow of ions (Catterall, 2000; Stojilkovic et al., 2010; Govorunova et al.,
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2015). Although the human body maintains a multitude of DE systems that contribute to its every
day function, a DE system responding specifically to sustained hazardous heart rhythm disturbances
seems not to have been evolved. Nevertheless, under natural cardiac electrophysiological condi-
tions, heart rhythm disorders can terminate spontaneously, resulting in non-sustained arrhythmias
(Bub et al., 2003; Katritsis et al., 2012). For those that are sustained, the most effective means for
acute restoration of sinus rhythm, especially in atrial and ventricular fibrillation (AF and VF), consists
of delivery of high-voltage shocks to the heart for arrhythmia termination (i.e. defibrillation)
(Wellens et al., 1998; Link et al., 2010; Laslett et al., 2012; Borne et al., 2013; Kumar and
Schwartz, 2014). This therapy is based on an electronic detector (i.e. sensor of electrical activity)
and effector (i.e. electroshock generator), which are incorporated into a single device. Implantation
of this device (the implantable cardioverter defibrillator or ICD) allows continuous monitoring of car-
diac rhythm in order to ensure rapid arrhythmia detection for automatic delivery of electroshocks.
Due to their non-biological nature, these electronic DE systems have a number of shortcomings
including limited battery lives, technical malfunction and inappropriate shock deliveries. However,
from a patient’s perspective, major concerns are the severe pain, anxiety and depression resulting
from the electroshocks (Sears et al., 2011), not to mention the possibility of permanent tissue dam-
age (Ashihara and Trayanova, 2005).
Now imagine that the mammalian heart itself would be able to detect and terminate an arrhyth-
mia in an automatic and repetitive manner just like the ICD, thereby eliminating the need for trauma-
tizing electroshocks. In this article, we present the theoretical fingerprints of a biological DE system
that is tailored to detect and terminate cardiac arrhythmias. We refer to it as the Biologically Inte-
grated Cardiac Defibrillator, or BioICD. We envision the BioICD as an ion channel of which the gat-
ing is customized to differentiate between sinus rhythm and arrhythmia, and to act accordingly.
Conceptually, such an ion channel could be implemented by proper choice of frequency-dependent
activation-inactivation kinetics. We use computer modelling to design the kinetics of this channel via
three different approaches and demonstrate the possibility for human cardiac tissue to auto-detect
and terminate tachyarrhythmias and fibrillation in both atria and ventricles once this type of channel
has been integrated. We prove the concept of our study in simulated monolayers of human cardio-
myocytes and in anatomically realistic in silico models of the human atrial and ventricular muscula-
ture, by showing that in each case considered, the arrhythmia can be detected and terminated to
restore sinus rhythm, within seconds of its initiation, on a fully biological basis. In order to provide
experimental evidence of the validity of the BioICD concept, we exploited the dynamic clamp tech-
nique (Wilders, 2006) to realise the designed BioICD function with the use of optogenetically modi-
fied human atrial myocytes that are optically stimulated at arrhythmic frequencies.
Results
Our concept of the BioICD involves the introduction of a new type of ion channel with specific prop-
erties into the sarcolemma of cardiac muscle cells, which is possible through genetic modification
(Nyns et al., 2016). We explored the properties of this ion channel in silico and found that in order
to provide the basis for a DE system, such channel should have the ability to sense the frequency of
electrical activation through gating mechanisms that are controlled by the cell’s membrane potential
(voltage difference across the cell membrane). In the subsequent sections, we show the behaviour of
a heart endowed with the new ion channel (referred to as ‘BioICD’), and compare it with the normal
‘Control’ situation.
Principle
In order to show the behaviour of the BioICD ion channel, we first demonstrate how it works in a
simplified controllable system, that is tachyarrhythmias in a 2D in silico model consisting exclusively
of isotropically arranged human ventricular myocytes. Three possible realisations of this ion channel
are provided, each of them relying on a different ionic mechanism: Model I is a minimal model that
allows frequency-dependent gating, Model II has a different inactivation mechanism, and Model III
has a gating mechanism insensitive to the shape of the action potential (AP). The results of Model II
and III can be found in the Supporting Information (Appendix 1 Figures 1, 2, 3). The detailed
description of Model I together with its results is provided below.
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Figure 1A illustrates the control situation for a simulation experiment in a monolayer without
expression of the BioICD channel. In this situation, induction of a figure-of-eight reentrant source,
via an extrasystole during sinus rhythm, results in a sustained reentrant tachyarrhythmia. In mono-
layers expressing the BioICD channel (see section BioICD model I below), the exact same stimulation
first leads to the development of the same reentrant pattern, however then, because of the concur-
rent increase in activation frequency, the BioICD channel is activated, resulting in termination of the
figure-of-eight reentry and restoration of sinus rhythm (Figure 1B). Representative voltage traces
(Figure 1C) demonstrate how the action of the BioICD channel can be recognized in the membrane
potential behaviour of a single cardiomyocyte. Of note, the presence of the BioICD channel exerts
no influence on wave propagation during sinus rhythm, both before and after the arrhythmia.
BioICD model I
The schematic representation of Model I is presented in Figure 2A. The ion channel comprises a
group of subunits that exhibit two states: open (O) and closed (C), with voltage-dependent transi-
tions between these states, indicated by arrows in Figure 2A. The ion channel subunits slowly move
to the open state O when voltage (V ) exceeds Vthreshold, (Vthreshold is typically around  60 mV). When
V<Vthreshold, the channel subunits move back to the closed state C. Thus, at any given moment in
time, the number of open subunits increases with the total time spent by the cardiomyocyte in the
suprathreshold (depolarized) state. This ensures that at low activation frequencies the subunits alter-
nate between open and closed states (black line in Figure 2B), whereas at high frequencies, tempo-
ral summation of activation leads to a higher number of subunits in the open state (black line in
Figure 2C). We assumed that the ion channel can produce current only if all of its identical subunits
are in an open state. Such collective kinetics is required to render the current amplitude sensitive to
changes in the activation frequency. In this case, the conductivity of the whole collection of n inde-
pendent, non-cooperative subunits is proportional to the nth power of O (the fraction of subunits in
the open state O). Higher values of n provide higher selectivity to the frequency changes, bringing it
closer to the all-or-nothing response. Given these conditions, we found that a good intermediate
Figure 1. Anti-arrhythmic action of the BioICD channel (Model I, see below). (A) Development of a sustained tachyarrhythmia, induced via an
extrasystole, in a simulated monolayer of normal human ventricular tissue (TNNP model; ten Tusscher and Panfilov, 2006). (B) Auto-detection and
termination of the tachyarrhythmia, followed by restoration of sinus rhythm in the same monolayer upon expression of the BioICD channel. (C) Voltage
traces recorded from representative cardiomyocytes (white asterisks) in the simulation domains (orange: Control, black: BioICD). Time frames in A-B are
chosen to represent the relevant stages in arrhythmia progression, detection and termination and therefore do not correspond linearly with the voltage
traces in C.
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solution for effective collective behaviour, which ensures simplicity (low n) and accuracy (high n), is
n ¼ 8. Because we require the BioICD channel to produce a depolarizing current upon activation (in
line with classical defibrillation), its reversal potential was set close to 0 mV, thus assuming a simple
pore without selectivity for any specific ion.
As channel activation occurs at high frequency, it only produces current after the onset of a tachy-
arrhythmia (i.e. after a substantial and sustained increase in activation frequency). Activation of this
channel raises the membrane potential everywhere in the tissue to » 0 mV, and the ion channel sub-
units continue to stay in the open state unless they are influenced to move back to the closed state
by some separate, yet integrated mechanism. Thus, we included an additional deactivation mecha-
nism to restore the initial closed state of the BioICD channel. A ‘deactivating agent’ a is designed to
accumulate in the a1 state if the membrane potential is close to 0 mV for a substantial amount of
time. Accumulation of a1 potentiates the deactivation of the BioICD channel (transition from open
state O to closed state C).
In electrophysiological terms, only if the cell stays depolarized longer than the normal duration of
the plateau in an AP, a1 accumulates and facilitates the closure of the BioICD channel. A complete
mathematical description and equations of this channel are given in the Materials and methods sec-
tion (Equations 1-6), and the anti-arrhythmic action of this ion channel at the tissue level is illustrated
in Figure 1.
Self-restoration of excitation rhythm in different virtual pathological
substrates
Sustained cardiac arrhythmias typically occur in diseased myocardial tissue. Our simulations of
human ventricular monolayers with BioICD channels demonstrate that abnormally fast rhythms can
be detected and terminated successfully in a variety of pathological substrates. This is illustrated in
Figure 3 (and also in Supporting Videos 1–4) for rotor-driven arrhythmias in substrates for (i) ventric-
ular tachycardia (VT) (Figure 3A and E), (ii) VF (Figure 3B and F), (iii) VT in fibrotic tissue (Figure 3C
and G) and (iv) VT in the presence of an anatomical scar (Figure 3D and H). In each case, the BioICD
channel activates within 1 s after initiation of the arrhythmias, thereby electrically synchronizing the
whole simulation domain within 300 ms and resetting all activity within 700 ms for VT based on func-
tional reentry (Figure 3A and E), 1000 ms for VF (Figure 3B and F) and VT in fibrosis (Figure 3C
Figure 2. Schematic diagram and behaviour of BioICD channel Model I. (A) Markov diagram for BioICD channel Model I. (B) and (C) Traces of voltage
(V ) and state variables O and a1, at 1.2 Hz and 4.2 Hz, respectively. O: open state of the frequency-sensing channel subunit, C: closed state of the
frequency-sensing channel subunit, a0: inactive state of the catalytic channel deactivation agent, a1: active state of the catalytic channel deactivation
agent. A detailed mathematical description of C, O, a0 and a1 is provided in the Materials and methods section.
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Figure 3. Self-restoration of excitation rhythm in human ventricular monolayers with reentrant tachyarrhythmias (TNNP model [ten Tusscher and
Panfilov, 2006]) for four different pathological substrates. (A) A substrate for VT. (B) A substrate for VF. (C) A substrate with diffuse fibrosis. (D) A
substrate with an anatomical scar. In each panel, successive frames (from left to right) show the voltage distribution in the monolayers at subsequent
relevant time points. The left column shows established reentrant tachyarrhythmias. The middle column shows, for the different arrhythmia conditions,
stages of advanced repolarization in the arrhythmia termination process (large dark blue areas), while the right column shows the final tissue-wide
repolarization (dark blue) stage, thereby allowing restoration of sinus rhythm (SR). The insets show the corresponding situation in the absence of BioICD
channels. (E–H) Voltage time series extracted from representative cardiomyocytes (white asterisks) in the simulation domains of situations A-D,
respectively. (I) The BioICD channel has no significant influence on the action potential (AP) at sinus rhythm (1.2 Hz, left AP traces), but slightly increases
Figure 3 continued on next page
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and G), and 600 ms for anatomical reentry (Figure 3D and H). Sinus rhythm resumes in all cases,
once the electrophysiological steady state has been restored. Thus, the entire process from arrhyth-
mia initiation to restoration of sinus rhythm takes about 2 s in the ventricular monolayers. In sub-
strates with more fibrosis (30% instead of 20% fibroblasts as in Figure 3C and G), our BioICD model
is still able to auto-detect and terminate VT albeit somewhat slower (data not shown).
As shown in Figure 3I, the presence of the BioICD channel exerts no significant influence on the
AP at sinus rhythm (1.2 Hz) (the black and orange traces coincide), but slightly increases the APD at
close-to-arrhythmic frequencies. This is also accounted for in the APD restitution curve of Figure 3J,
which shows that the BioICD channel effectively increases the minimal APD of the cardiomyocytes.
As a consequence of their sensitivity to frequency, the BioICD channels are unable to detect and
eliminate reentrant activity anchored to scars if the activation frequency is too low, for example in
substrates with large scars (see Video 5 in the Supporting Information).
Self-restoration of excitation rhythm in the virtual human heart with
sustained fibrillation
Next, we incorporated the BioICD channel in cardiomyocytes of anatomically realistic human atria
and ventricles. We find that the same channel successfully detects and terminates sustained fibrilla-
tion in both ventricles and atria to restore sinus rhythm, as illustrated in Figure 4A and B (the corre-
sponding videos can be found in Supporting Information Videos 6–7). The mechanism of
defibrillation is similar to that in monolayers. Arrhythmia-triggered activation of the BioICD channel
in some regions leads to complete reset of the cells, whereas in others it prolongs APD, leading to
extinction of the arrhythmia sources. With our choice of parameters, the BioICD channels in human
atria could detect ongoing AF within 1.7 s and terminate it within 1.2 s to restore sinus rhythm. The
corresponding channels in the ventricles could detect VF within 3 s and terminate it within 500 ms to
restore sinus rhythm.
Figure 3 continued
the AP duration in the tail (APD90) at close-to-arrhythmic frequencies (right AP traces). The dotted line of the widest AP in the right traces shows the AP
at 1.2 Hz for reference. The orange lines show the APs without BioICD current (control). (J) APD restitution curve for the original parameters of the
human ventricular cardiomyocyte model, with and without BioICD channel. Orange shading is used to indicate the region of the restitution curve where
the slope exceeds 1. DI, diastolic interval.
Video 1. Self-restoration of cardiac excitation rhythm
after VT in monolayers of human ventricular tissue. The
activation of the BioICD current is shown in grey, as an
overlay on the voltage map in the BioICD case.
https://elifesciences.org/articles/55921#video1
Video 2. Self-restoration of cardiac excitation rhythm
after VF in monolayers of human ventricular tissue. The
activation of the BioICD current is shown in grey, as an
overlay on the voltage map in the BioICD case.
https://elifesciences.org/articles/55921#video2
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Self-restoration of excitation
rhythm in human atrial myocytes
In order to assess, in actual cardiomyocytes, the
anti-arrhythmic effect of the BioICD channel, the BioICD current was mimicked in vitro using dynamic
patch-clamping (Wilders, 2006). This technique can be used to introduce virtual voltage-gated ion
channels (like the BioICD channel) into electrically
excitable cells such as cardiomyocytes, in this
case human atrial myocytes derived from a condi-
tionally immortalized cell line (Harlaar et al.,
2019; Figure 5A). These cells were optogeneti-
cally modified (Feola et al., 2016; Figure 5E) to
control their excitation rhythm by light using a
dynamically controlled LED source. The dynamic
clamp experiment was carried out in current
clamp mode, which allowed the unbiased record-
ing of the membrane potential as it develops as
the net result of the activity of all endogenous
ion channels and the BioICD channel. The real-
time measured membrane potential was used to
calculate the amplitude of the BioICD current,
which was injected into the cell via the recording
electrode. A real-time interface between the
patch-clamp amplifier and a computer consti-
tuted the feedback loop (Figure 5B) that allowed
us to mimic the presence of the BioICD channel,
and to observe the effects of BioICD channel
activity in cardiomyocytes (Figure 5C–D).
To simulate arrhythmia conditions, light pacing
was switched from 1 Hz to high frequency pacing
(Figure 5C–D). We found that the same ion chan-
nel gating properties used for the in silico studies
Video 3. Self-restoration of cardiac excitation rhythm
after VT in monolayers of human ventricular tissue, in
the presence of 20% fibroblasts. The activation of the
BioICD current is shown in grey, as an overlay on the
voltage map in the BioICD case.
https://elifesciences.org/articles/55921#video3
Video 4. Self-restoration of cardiac excitation rhythm
after VT in monolayers of human ventricular tissue, in
the presence of an anatomically realistic scar (3.4 cm
long), surrounded by a grey zone, where IKs was
reduced by 80%, IKr by 70%, ICaL by 69% and INa by
62%. The activation of the BioICD current is shown in
purple, as an overlay on the voltage map in the BioICD
case.
https://elifesciences.org/articles/55921#video4
Video 5. Failure of self-restoration of cardiac excitation
rhythm after VT in monolayers of human ventricular
tissue, in the presence of a large anatomically realistic
scar (5.8 cm long), surrounded by a grey zone, where
IKs was reduced by 80%, IKr by 70%, ICaL by 69% and
INa by 62%. The activation of the BioICD current is
shown in grey, as an overlay on the voltage map in the
BioICD case.
https://elifesciences.org/articles/55921#video5
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successfully detected fast pacing rhythms in a living cell. While no significant distortions of AP were
registered at 1 Hz (the black and orange traces coincide), the depolarizing current produced by the
BioICD channel at high frequencies built up resulting in APD prolongation. In tissue, the cells depo-
larised by the BioICD current would create conduction block to ‘defibrillate’. In order to simulate
this tissue-level feedback in a single-cell set-up, the light-pacing protocol was augmented with a
feedback mechanism that detected pacing block (simulating conduction block in tissue) and subse-
quently lowered the pacing frequency, leading to restoration of the original cardiac excitation
rhythm. Figure 5F shows a zoom-in of panel 5C focussing on the termination phase.
This process of arrhythmia detection, current accumulation, and pacing block is frequency-depen-
dent, as evidenced by the smaller time until termination following 8 Hz optical pacing (1.16 s,
Figure 5D) versus 7 Hz pacing (1.92 s, Figure 5C) within the same cell. The frequency at which termi-
nation occurs is also dependent on the baseline APD (Figure 5G). For a total of 7 cells showing dif-
ferent baseline APDs (APD at 90% of repolarization (APD90) measured at 1 Hz), basic cycle length
(BCL) was decreased slowly (frequency was increased) to find the maximal BCL at which self-restora-
tion of excitation rhythm would occur. Upon an increase in baseline APD, the BioICD channel is acti-
vated earlier, namely at longer BCLs. Collectively, these findings show that the proposed ionic
gating mechanism is able to restore cardiac excitation rhythm in living excitable cells.
Discussion
In this study we present evidence that the heart itself may be empowered to detect and terminate
arrhythmias. This is achieved by adding only one additional type of customized ion channel, with tai-
lored frequency-dependent gating properties, to the existing repertoire of ion channels. In virtual
Figure 4. Self-restoration of excitation rhythm in anatomically realistic models of human (A) atria and (B) ventricles with reentrant arrhythmias using
BioICD channel Model I (more depolarised regions are more transparent). The upper panels show representative plots of the control situation (in the
absence of a BioICD channel). Induction, during sinus rhythm, of reentrant activity by giving an extra external stimulus leads to sustained AF and VF in
atria and ventricles, respectively. The lower panels show the exact same situation, but in atria and ventricles expressing the BioICD channel. Once the
arrhythmia is induced, the heart itself is able to detect and terminate fibrillation in order to restore sinus rhythm.
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hearts equipped with this so-called BioICD chan-
nel, sinus rhythm is rapidly restored after arrhyth-
mia initiation, in a fully automatic and shock-free
manner without the need of a non-biological
factor.
Regarding the customized gating properties
of the BioICD ion channel, we show that,
amongst the parameters characteristic for tachy-
arrhythmia or fibrillation, even an obvious one
like its frequency can already provide a basis for
the detection mechanism. Here, arrhythmia
detection relies on positive feedback upon fre-
quency increase. We propose three possible real-
isations of such anti-arrhythmic gating, as
described in the different BioICD models I-III.
However, these should not be viewed as the ultimate designs of a BioICD channel, but more as a
first set of rigorous outlines that can serve as a basis for additional research now that the concept
has been proven in the virtual human heart. Our model can be further improved or modified in sev-
eral aspects (see Supplementary Information), for example the power n can be lowered. In proteins,
this can result in a good trade-off between the detecting-terminating abilities of the BioICD ion
channels and their complexity. Also, changing time constants will alter the activation time course of
the channel, which can result in a shorter or longer delay preceding arrhythmia termination. Indeed,
the structure of our BioICD model allows ample freedom to choose kinetic as well as threshold
parameters for the channel within certain limits. As proof-of-principle in the virtual human heart, we
tested the BioICD channels in homogeneous, anatomically realistic atria and ventricles. Based on our
dynamic patch-clamp experiments, we conjecture that the model should also work for pathological
substrates where the arrhythmia comes with an increase in activation frequency. This is based on the
notion that the mechanism for self-restoration of cardiac excitation rhythm relies only on the detec-
tion of high-frequency signals, irrespective of the nature and underlying cause of the arrhythmia.
Having explained the guiding principles behind the functioning of BioICD channels at the cellular
level, we find it fascinating to consider the resemblance between functioning of these ion channels
at the organ level and ‘spontaneous termination’ of arrhythmias. Note that, in nature, not all high-
frequency arrhythmias are sustained. A significant fraction does get self-terminated (Josephson and
Kastor, 1977), although the mechanisms behind such spontaneous termination are still up for specu-
lation. For example, reentrant circuits can act as feedback systems in which changes in the duration
of one cycle have the potential to affect conduction in the subsequent cycles (Frame and Rhee,
1991). Cycle length was found to oscillate with progressively increasing alternations of long and
short periods until a sufficiently short cycle led to conduction block (Ortiz et al., 1993; Frame and
Simson, 1988; Quan and Rudy, 1990). A feedback system with the aforementioned characteristic
was studied in silico and in vivo in the atrioventricular-node (Simson et al., 1981; Sun et al., 1995).
Also, a frequency-based feedback system exists in the atrioventricular and sinoatrial nodes in the
heart, where overdrive suppression creates block
of nodal activation (Kunysz et al., 1995; Vas-
salle, 1970; Kunysz et al., 1997). In addition,
Nagai et al., 2000 demonstrated a way to end
paroxysmal arrhythmias based on overdrive sup-
pression in a circular ring of regular cardiac cells
interspersed with two pacemakers. Interestingly,
whereas unstable tachycardias demonstrate cycle
length oscillations that can lead to spontaneous
termination of the tachycardia, stable tachycar-
dias exhibit damped oscillations when perturbed.
Despite the phenomena discussed above, these
damped oscillations can still lead to sustained
reentry. In the present study, we focused on
developing a DE system capable of handling
Video 6. Self-restoration of cardiac excitation rhythm
after VF in anatomically realistic human ventricles.
https://elifesciences.org/articles/55921#video6
Video 7. Self-restoration of cardiac excitation rhythm
after AF in anatomically realistic human atria.
https://elifesciences.org/articles/55921#video7
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Figure 5. Self-restoration of excitation rhythm in cultured human atrial myocytes (AM) with the help of dynamic patch-clamping using BioICD channel
Model I. (A) Human atrial myocytes stained for (from left to right) a-actinin (ACTN2), enhanced yellow fluorescent protein (eYFP) and DNA. (B) Dynamic
patch-clamp set-up creating a feedback system for current injection and optical pacing. (C) Typical membrane potential (Vm) and injected current (Iinj)
traces with and without the BioICD current (IBioICD) enabled at 7 Hz. Both traces are from the same cell and were recorded 7 s apart. Dots indicate the
stimulus times. (D) Typical membrane potential and injected current traces with and without the BioICD current enabled in the same cell as (C) at 8 Hz.
Also here, both traces were recorded 7 s apart. (E) eYFP fluorescence produced by optogenetically modified human atrial myocyte. (F) Zoom-in of the
trace in (C) showing termination of arrhythmic activity. The last optical stimulus is blocked, allowing 1 Hz activation to regain. (G) Maximal basic cycle
length (BCL) for which termination still occurs as a function of baseline APD. Data obtained from 7 cells. Other abbreviations: real-time (RT), analog/
digital (A/D), voltage input for the LED driver (VLED), current output of the LED driver (ILED).
The online version of this article includes the following source data for figure 5:
Source data 1. Dynamic clamp reading 1: CSV-file containing the raw data for the C-panel in Figure 5.
Source data 2. Dynamic clamp reading 2: CSV-file containing the raw data for the D-panel in Figure 5.
Source data 3. Dynamic clamp summary table: Table containing the experimental datapoints that were plotted in Figure 5G.
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sustained arrhythmias, including the most hazardous ones like fibrillation. This concept came to
expression in the design of anti-arrhythmic ion channel gating, that is the BioICD channel.
As a consequence of the design, this particular BioICD model allows for the detection and elimi-
nation of relatively fast sustained rhythms, thereby targeting those arrhythmias that require interven-
tion for acute termination. This means that relatively low frequency arrhythmias are not detected by
the BioICD channel and are therefore also not terminated. An example is a reentrant wave anchored
to an anatomical obstacle (i.e. a scar) with a large perimeter (see Supporting Information, Video 5).
In this case, the period of rotation, which is determined by the perimeter of the scar and directly
related to the activation frequency, stays below the detection threshold. Thus, the abnormal electri-
cal activity sustains in the cardiac tissue, despite the presence of the BioICD channel. However, as
low-frequency arrhythmias are considered to be less hazardous than those with a high frequency,
like fibrillation, they can be managed otherwise (Cho and Marbán, 2010; Stevenson, 2013;
Nattel et al., 2014; Bongianino and Priori, 2015). Alternatively, other biological arrhythmia detec-
tion mechanisms could be explored and developed if needed.
Additional next steps in developing the BioICD channel, from a computational point of view,
should be (i) extending the space of synthetic models, together with (ii) modifying existing in silico
models of known ion channels to propose a candidate for experimental realization. Indeed, future
research should lead to identification of the most robust and broadly applicable BioICD channel with
the highest translational potential. We believe that, for the construction of a BioICD channel, all the
essential knowledge about ion channel structure-function relationships (Börjesson and Elinder,
2008; Catterall, 2010; Moreau et al., 2014), as well as the molecular tools to manipulate these rela-
tionships in a systemic and rational manner are available (Bayley and Jayasinghe, 2004;
Subramanyam and Colecraft, 2015). The ion channels from which functions can serve as a blueprint
are not limited to eukaryotic organisms only, but encompass prokaryotic ones as well (Ren et al.,
2001; Martinac et al., 2008) and can be searched for in extensive databases, such as the IUPHAR/
BPS (Southan et al., 2016). Also, the field of optogenetics has allowed the study of biological
arrhythmia termination and could thereby add to the translation of our findings (Boyle et al., 2018;
Entcheva and Bub, 2016; Boyden et al., 2005). Here, cardiomyocytes are genetically modified to
express light-gated ion channels, allowing control of electric current generation in these cells by
light. In earlier work from our group and others, it was shown that cardiomyocytes are indeed able
to generate sufficient electrical current, based on the natural electrochemical gradients, for biologi-
cal auto-termination of both atrial and ventricular arrhythmias, including fibrillation. This was shown
in vitro using monolayers of neonatal atrial myocytes (Bingen et al., 2014), but later also in the
whole heart of adult rodents (Bruegmann et al., 2016; Crocini et al., 2016; Nyns et al., 2016), and
most recently also integrated in a hybrid bio-electronic system (Nyns et al., 2019). In these studies,
the gating of ion channels was controlled by light to terminate cardiac arrhythmias. As a next step,
we now show how such gating could be controlled by the arrhythmia itself, thereby giving rise to a
new fully biological DE system.
In this study, we used optogenetics to provide experimental proof of the aforementioned con-
cept with the use of human atrial myocytes. These atrial myocytes were optogenetically modified
and used in dynamic patch-clamp experiments to separate the pacing mechanism (optical) from the
rhythm restoration mechanism (chemical/electrical) in order to improve signal interpretation, that is
stimulation block at depolarised membrane potentials. Our studies reveal that the in vitro data
(Figure 5C–D) show the same phenomenological phases as visible in the traces coming from the in
silico simulations (Figure 1). Because the BioICD channel is capable of restoring normal excitation
rhythm in cells with short baseline APDs under high frequency, the design of the gating properties
makes that such restoration will work also for cells with long baseline APDs (Figures 2 and 5G), like
those found in ventricular myocytes. This motivated our decision to use an atrial cell line for the
experimental validation of our proposed concept.
Taken together, our study presents insight into acquired homeostatic regulation of excitation
rhythm under disturbed conditions, including cardiac fibrillation. It is shown, by a combination of
theoretical and experimental studies, that such regulation can be established by creation of a biolog-
ically engineered DE system for arrhythmias through expression of customized ion channels. Self-
resetting of an acutely disturbed heart rhythm by an engineered biological DE system may yield
unique insight into arrhythmia management and may lay the foundation for the development of dis-
tinctively innovative treatment options by the creation of new biology for therapeutic purposes,
Majumder et al. eLife 2020;9:e55921. DOI: https://doi.org/10.7554/eLife.55921 11 of 23
Research article Computational and Systems Biology Physics of Living Systems
ultimately leading to acute, yet trauma-free termination of arrhythmias. This would stretch the field
of synthetic biology into cardiology and also provide a radically new perspective for other medical
fields, given the general nature and versatility of biological DE systems. This perspective involves
that a diseased organ, begets its own remedy, for example a Biologically Integrated Cardiac Defibril-
lator (BioICD) in case of the heart.
Materials and methods
Key resources table
Reagent type
(species) or resource Designation Source or reference Identifiers
Additional
information
Cell line
(Homo-sapiens)
Conditionally
immortalised
human atrial
cell line
DOI: 10.1093/eurheartj
Gene
(Chlamydomonas
reinhardtii)
ChR2(H134R) Addgene plasmid #26973 source of the
H134R variant of
channelrhodopsin 2
Genetic reagent LVV-ChR2(H134R) This paper Lentiviral vector
particles to transduce
and express
ChR2(H134R)
Software,
algorithm
graphics
processing
unit-usable
code
DOI: 10.1152/ajp-heart.00109.2006,
DOI: 10.1038/srep20835
Software,
algorithm
RTXI dynamic
clamp software
DOI: 10.1371/journal. pcbi.1005430
Detailed formulations for our BioICD ion channel model, based on a Markov chain formalism (Her-
manns, 2002; Rudy and Silva, 2006), are provided below.
BioICD model I
Total BioICD current is expressed as:
IBioICD ¼GBioICDO
8ðV  EBioICDÞ: (1)
where GBioICD ¼ 150 nS=pF is the maximal conductance, and EBioICD ¼ 0mV denotes the reversal
potential of the BioICD channel. There is a frequency-sensing channel subunit with 2 states: open
(O) and closed (C). Eight subunits together compose a BioICD channel. Deactivation of the channel
is facilitated with a catalytic agent (a), which has 2 states: inactive a0 and active a1. These states
evolve according to Equations 2, 3, 4, 5, 6:
qO
qt
¼
kCOC  k
0
OCða1ÞO
t o
; (2)
qa1
qt
¼
k01a0   k10a1
t a
; (3)
k0OCða1Þ ¼kOC þKOCða1Þ; (4)
CþO¼1 (5)
a0þ a1 ¼1 (6)
where t o ¼ t a ¼ 1400ms is the characteristic time, KOCða1Þ ¼ 2  10
4a1
5, and kCO, kOC, k01, and k10 are
functions of voltage that determine the opening and closing rates:
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kCO ¼
0:0 if V<  60mV;
1:0 otherwise;

(7)
kOC ¼
7:0 if V<  60mV;
0:0 otherwise;

(8)
k01 ¼
1:0 if  5 5mV<V<0mV;
0:0 otherwise;

(9)
k10 ¼
0:0 if  55mV<V<0mV;
200:0 otherwise:

(10)
Here, we assume that the number of catalyst molecules in the cell is much higher than the number
of BioICD channels, such that the binding between them does not significantly change the number
of active catalysts a1. The fifth power of a1 in KOCða1Þ stands for the non-cooperative binding of 5
catalyst molecules to the BioICD channel. The full detailed Markov chain model for this process
requires a large number of catalyst-bound states. This type of models can often be reduced to lower
dimensions, as described by Keener, 2009. We thus substituted the complex catalyst-binding pro-
cess with an extra facilitated flow from state O to state C. The reduced model reproduces the same
overall kinetics of the O!C catalysed reaction and is more suitable for whole-heart simulations due
to its simplicity.
Human cardiac tissue model
To study the effect of the BioICD channel in human cardiac tissue, we integrated the BioICD channel
model as a conductance into the electrophysiological model of each cardiomyocyte. For human ven-
tricular tissue, the mathematical model proposed by Ten Tusscher et al., 2009 was used, where the
transmembrane voltage (V ) is calculated in millivolts (mV) according to Equation 11:
qV
qt
¼r ~DrV
  
 
Iionþ Istim
Cm
; (11)
where t is time in milliseconds (ms), Iion is the total ionic current density in micro-amperes per square
centimetre (mA/cm2), Istim is the external stimulus current, Cm is the specific membrane capacitance in
microfarad per square centimetre (mF/cm2), and ~D is the diffusion tensor, whose components are
related to the electrical conductivity of cardiac tissue in each direction of propagation.
Iion ¼ INa þ ICaL þ IK1 þ Itoþ INaCa
þINaK þ IKr þ IKs þ IbNaþ IbCaþ IpCaþ IpK
þIBioICD:
(12)
Here, the different cardiac currents are represented as follows: INa: the fast Na
þ current, ICaL: the
L-type Ca2þ current, IK1: the inward-rectifier K
+ current, Ito: the transient outward K
+ current, INaCa:
the Naþ=Ca2þ exchanger current, INaK : the Na
þ=Kþ pump current, IKr: the rapid delayed rectifier K
+
current, IKs: the slow delayed rectifier K
+ current, IbNa: the background Na
þ current, IbCa: the back-
ground Ca2þ current, IpCa: the plateau Ca
2þ current, and IpK : the plateau K
+ current. Units for con-
ductance measurements (GX ) and measurements of intracellular and extracellular ionic
concentrations (½Xi and ½Xo), are in nanosiemens per picofarad (nS/pF) and millimole per litre (mM),
respectively.
For simulations of Figure 3, we used a monolayer model, containing 512  512 grid points, such
that the physical size of the simulated tissue was 12.8  12.8 cm. Our model for fibrosis contained
20% randomly distributed fibroblasts, which did not couple electrotonically to the neighbouring car-
diomyocytes (Ten Tusscher and Panfilov, 2007). For simulations with the realistic scar, a grey bor-
der zone (GZ) was taken into consideration. In the GZ, IKs was reduced by 80%, IKr by 70%, ICaL by
69% and INa by 62% (Arevalo et al., 2013).
For human atrial tissue, data and fibre directions were obtained from Dössel et al., 2011. The
ionic cell model that was used is the AF-induced electrically remodelled human atrial
Courtemanche et al., 1999 model (adapted from Courtemanche et al., 1998, which was taken
from CellML (Yu et al., 2011) with the use of Myokit (Clerx et al., 2016) and transformed to
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graphics processing unit-usable code). The transmembrane voltage (V ) is described in millivolts (mV)
according to Equation 12 with IpK replaced by IKur, an ultra-rapid delayed rectifier K
+ current.
We used an S1-S2 cross-field protocol to generate spiral and scroll waves (ten Tusscher and Pan-
filov, 2006). In human ventricular monolayers, we assumed isotropy. Thus, the diffusion tensor of
Equation 11 could be replaced by a scalar coefficient D. However, in 3D, owing to the natural
anisotropy of realistic cardiac tissue, the elements were computed on the basis of a reconstructed
fibre direction field as described by Ten Tusscher et al., 2009. The transverse diffusion coefficient
(Dt, for signal propagation across the fibers) was assumed to be 4 (ventricles) or 6 (atria) times less
than the longitudinal diffusion coefficient (Dl, for signal propagation along the fibers). Elements of
the diffusion tensor were computed as follows:
Dij ¼ ðDl DtÞaiaj þDtdij; (13)
where ai are components of the unit vector that is oriented along the direction of a fibre. We used
Dl ¼ 1:54 cm
2=s for ventricles and Dl ¼ 1:6 cm
2=s for atria.
We integrated Equation 11 in time using the forward Euler method with time step dt ¼ 0:02 ms
(ventricular model) or dt ¼ 0:01 ms (atrial model), and in space, using the centred finite-differencing
scheme with space step dx ¼ dy ¼ 0:025 cm in monolayers, 0.05 cm in whole ventricles and 0.0330
cm in whole atria, subject to ‘no flux’ boundary conditions. The simulation domains for the whole
ventricles and atria contained 1, 693, 010 and 2, 173, 891 grid points, respectively. The gating varia-
bles in the electrophysiological model for the human cardiomyocyte were integrated using the
Rush and Larsen, 1978 scheme.
Cell lines
The cell line used in this study has recently been generated by transducing human foetal atrial myo-
cytes with a human immunodeficiency virus type 1-based vector conferring doxycycline-controlled
expression of simian virus 40 large tumour antigen as described in Harlaar et al., 2019. The cells
were tested negative for the presence of mycoplasma by the MycoAlert mycoplasma detection kit
(Lonza, Basel, Switzerland), as well as by Hoechst 33342 (Life Technologies Europe, Bleiswijk, the
Netherlands) staining of Vero cells cultured with conditioned human atrial myocyte medium.
Preparation of ChR2(H134R)-expressing human atrial myocytes
Self-inactivating lentiviral vector particles encoding an eYFP-tagged version of the H134R mutant of
Chlamydomonas reinhardtii channelrhodopsin 2 (LVV-ChR2(H134R)), were created by standard labo-
ratory procedures (Feola et al., 2016) and used to transduce human atrial myocytes differentiated
from a conditionally immortalised cell line (Harlaar et al., 2019). On the day before the patch-clamp
experiments, cells were dissociated and re-plated on fibronectin-coated glass coverslips at 2.5  104
cells per well in 24-well culture plates (Greiner Bio-One, Alphen aan den Rijn, the Netherlands).
Electrophysiological analysis
APs were recorded in single cells or small clusters of cells using the amphotericin-B perforated
patch-clamp technique (Wilders, 2006). Voltage control, data acquisition, and analysis were accom-
plished with custom-made software. Potentials were corrected for the calculated liquid junction
potential (Barry and Lynch, 1991). Signals were low-pass-filtered (cut-off of 5 kHz) and digitized at
5 kHz. Cell membrane capacitance (Cm) was estimated by dividing the time constant of the decay of
the capacitive transient in response to 5 mV hyperpolarizing voltage clamp steps from  40 mV by
the series resistance.
APs were measured at 36 ± 0.2˚C in extracellular solution containing (in mM): NaCl 140, KCl 5.4,
CaCl2 1.8, MgCl2 1, glucose 5.5, HEPES 5; pH 7.4 (NaOH). Pipettes (resistance 2.5   3 MW) were
pulled from borosilicate glass capillaries (Harvard Apparatus, Cambourne, UK) using a custom-made
microelectrode puller, and filled with solution containing (in mM): K-gluconate 125, KCl 20, NaCl 5,
amphotericin-B 0.44, HEPES 10; pH 7.2 (KOH). APs were elicited by 10 ms pulses of light (470 nm,
3mW/mm2). The light source comprised of a 470L3-C4 mounted LED (Thorlabs, Newton, NJ), driven
by the LEDD1B modulated power supply. Light was delivered via the COP1-A collimation lens
assembly (Thorlabs, Newton, NJ) positioned above the bath at a distance of 15 cm.
Majumder et al. eLife 2020;9:e55921. DOI: https://doi.org/10.7554/eLife.55921 14 of 23
Research article Computational and Systems Biology Physics of Living Systems
Dynamic clamp protocol
A Linux computer running RTXI dynamic clamp software (Patel et al., 2017) with a time step
Dt ¼ 50 s allowed real-time dynamic interaction between the input and output channels of the
patch-clamp amplifier. At a variety of frequencies, an optical stimulus train was applied that con-
sisted of the following phases: i) 7 pulses of pre-pacing are applied at 1 Hz with the BioICD channel
enabled, ii) 8 pulses are applied at 1 Hz with the BioICD channel still enabled, iii) an undetermined
number of pulses is applied at increased frequency with the BioICD channel enabled, either until ter-
mination occurs due to the feedback mechanism, or until a stable state has been achieved (in which
case the protocol is terminated), iv) after restoration of excitation rhythm, another 7 pulses are
applied at 1 Hz with the BioICD channel enabled, v) 8 pulses are applied at 1 Hz with the BioICD
channel disabled, vi) an undetermined number of pulses is applied at increased frequency with the
BioICD channel still disabled until the stimulus train is stopped externally. The feedback mechanism
detected refractory beats as defined by membrane potential values more positive than
 20 mV during the entire pulse duration.
Data and software availability
The key component of the graphics processing unit-usable code that is sufficient for reproduction of
the results was made readily available. More detailed information about the data and software that
support the findings of this study are available from the corresponding author upon reasonable
request.
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Appendix 1
We have designed two alternative schemes of an anti-arrhythmic gating mechanism that can
also be used for a BioICD channel. Each scheme, shown as a Markov diagram, has its own
strengths and weaknesses, as will be discussed below. We will denote them as Model II and
Model III, and will refer to the model from the main text as Model I. BioICD Model I seems to
be the easiest to engineer out of the three virtual BioICD channels, and therefore was selected
for a more detailed study in 2D and 3D (see the Results section).
Model II
In this model, we use a similar concept as in Model I, but with a different inactivation
mechanism. The activation process is similar to Model I, with a closed state C and an open
state O. Inactivation occurs through a dedicated gate that has two states IO (open) and
IC (closed). This gate is responsible for recovery of the channel after defibrillation and
inactivates the current after » 500 ms. Here too, the BioICD channel makes use of the
‘deactivating agent’ a, which in contrast to model I accumulates in the state a1 during the
diastolic phase (i.e. phase 4) of the AP. Thus, when the transmembrane potential of the
cardiomyocyte is restored to its resting value, a1 increases. This triggers a transition from the
open state O to the closed state C (deactivation) with a decreased time constant, thereby
leading to restoration of sinus rhythm. A schematic diagram of this model and its behaviour is
presented in Appendix 1—figure 1. A detailed mathematical description of the state
variables is provided in in Equations 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26.
Appendix 1—figure 1. Schematic diagram and behaviour of BioICD channel Model II. (A)
Markov diagram for BioICD Model II. (B) and (C) Traces of voltage (V ) and state variables at
1.2 Hz and 4.2 Hz, respectively.
Total BioICD current is expressed as:
IBioICD ¼GBioICD IO HðO OthrÞðV  EBioICDÞ: (14)
Here, GBioICD ¼ 10 nS=pF is the maximal conductance of the whole collection of channels,
Othr ¼ 0:25, H is a Heaviside function, and EBioICD ¼ 0mV is the reversal potential. Rate
coefficients have explicitly been provided a dimensionality, while in Model I and III the kinetic
coefficients are divided by a characteristic time.
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qO
qt
¼aCþgIO ðbþ dÞO; (15)
qIC
qt
¼dCþbIO ðaþgÞIC; (16)
qIO
qt
¼dOþaIC  ðbþgÞIO; (17)
where
a¼
0 s 1 ifV<  55:0mV;
1 s 1 otherwise;

(18)
b¼
2s 1 ifV<  60:0mV;a1<athreshold;
1ms 1 ifV<  60:0mV;a1  athreshold;
1s 1 if  60:0mV V<  55:0mV;
0
 1 otherwise:
8
>
>
<
>
>
:
(19)
OþCþ IOþ IC ¼ 1;(20)
a0 þ a1 ¼ 1:(21)
In our 2D model, we used athreshold ¼ 0:5
g¼
0 s 1 if V <  60:0mV;
10
 1 otherwise;

(22)
d¼
10 s 1 if V<  60:0mV;
0 s 1 otherwise:

(23)
Subunit a has active (a1) and inactive (a0) states.
qa1
qt
¼ k01a0  k10a1: (24)
Transition rates between them are the following:
k01 ¼
1:0
1:0þ e Vþ60:0ð Þ=0:1ð Þ

2s 1; V<  60:0mV
1ms 1; otherwise;
;

(25)
k10 ¼
1:0
1:0þ e  Vþ60:0ð Þ=0:1ð Þ

2 s 1; V<  60:0mV
1ms 1; otherwise:
;

(26)
Model III
This model comprises six identical subunits with four states each (see Appendix 1—figure
2A): I (inactive state), C1 (1st closed state), C2 (2nd closed state) and O (open state). The
mechanism is less sensitive to the changes in AP shape or duration by design, but requires
more states in a Markov chain model.
Initially, all subunits are in the first closed state C1. When the cell depolarizes (V>  25 mV ),
most of the subunits of the channel transit to the inactive state I, whereas the remaining
fraction of subunits change conformation to the other closed state C2. The number of subunits
in the second closed state (C2) always increases approximately to the same value after each
upstroke (see green spikes of C2 in Appendix 1—figure 2B and C). The channel can then
open from the C2 state, but not from C1 or I. The opening and inactivation from the C2 state
occurs slowly and independent of the voltage (k4, k5), which slows down the overall kinetics of
the channel. Therefore, the number of open channels (O) reflects the average/integrated
number of upstrokes in a unit of time (see Appendix 1—figure 2B and C, black lines). The
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channels recover from inactivation mainly during the late phase of the AP, when the
transmembrane voltage ranges from  60 mV to  25 mV (as can be seen in Appendix 1—
figure 2B and C by an increase of C1 during the final phase of the AP). At high frequencies,
the number of channels in the second closed state C2 and in the open state O increases. The
channels with all subunits in the open state contribute to the defibrillation current. After
arrhythmia termination, in the absence of new upstrokes, the subunits of the channels recover
fast to the first closed state C1 (see Appendix 1—figure 2B and C, orange line). The Markov
diagram for this model is shown in Appendix 1—figure 2A. A detailed mathematical
description of the state variables is provided in Equations 27, 28, 29, 30, 31).
Appendix 1—figure 2. Schematic diagram and behaviour of BioICD channel Model III. (A)
Markov diagram for BioICD Model III. (B) and (C) Traces of voltage (V ) and state variables at
1.2 Hz and 4.2 Hz, respectively.
Total BioICD current is expressed as:
IBioICD ¼GBioICDO
6ðV  EBioICDÞ; (27)
where GBioICD ¼ 1000 nS=pF and EBioICD ¼ 0mV.
qC1
qt
¼
k1I  k2C1   k3C1
t
; (28)
qC2
qt
¼
k3C1  k4C2  k5C2
t
; (29)
qO
qt
¼
k4C2  k6O
t
; (30)
IþC1 þC2 þO¼ 1; (31)
where t ¼ 7ms and k1, k2 and k3 are functions of voltage:
k1 ¼
1:0 if -60 mV<V <-25 mV,
0:0 otherwise,

(32)
k2 ¼
30:0 if V >-25mV,
0:0 otherwise,

;k3 ¼
10:0 if V >-25mV,
0:0 otherwise.

(33)
Other kinetic coefficients are constant: k4 ¼ 0:05, k5 ¼ 0:01, and k6 ¼ 0:05.
Finally, in Appendix 1—figure 3 we demonstrate the operation of our BioICD Model II and
Model III in simulated homogeneous human ventricular monolayers. In each case, the channel
remains closed during sinus rhythm. However, upon arrhythmia initiation, such abnormal
electrical activity is terminated within 1.2 s by transient activation of the BioICD channel
resulting in the restoration of sinus rhythm.
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Appendix 1—figure 3. Anti-arrhythmic action of BioICD Model II and III in monolayers of human
ventricular tissue (TNNP model). (A and B) Pseudocolor plots of subsequent time frames of the
process of biological auto-detection and termination of reentrant tachyarrhythmias, followed
by restoration of sinus rhythm, as demonstrated by using BioICD Model II and Model III,
respectively. (C and D) Voltage traces from representative cardiomyocytes (white asterisks) in
the simulation domains for Model II and Model III, respectively.
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